{
    "title": "Astrazeneca boss damns critics of \u00a329bn deal to buy Alexion, pledging it will propel company to top of FTSE 100",
    "url": "https://www.dailymail.co.uk/money/markets/article-9090965/Astrazeneca-boss-damns-critics-29bn-deal-buy-Alexion.html",
    "date": "2020-12-27",
    "keywords": [
        "share",
        "soriot",
        "alexion",
        "company",
        "price",
        "fund",
        "acquisition",
        "cent",
        "fall",
        "companys",
        "stock",
        "time",
        "pharma",
        "investment",
        "account",
        "fee",
        "executive",
        "deal",
        "top",
        "ftse",
        "specialist",
        "pricehe",
        "drop",
        "hedge",
        "strategy",
        "oncology",
        "business",
        "chance",
        "london",
        "exchange",
        "immunology",
        "progress",
        "brummer",
        "giant",
        "astrazeneca",
        "drug",
        "rival",
        "article",
        "astrazenecas",
        "vaccine",
        "oxford",
        "university",
        "cost",
        "firm",
        "climb",
        "diy",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}